1997
DOI: 10.1023/a:1008252227512
|View full text |Cite
|
Sign up to set email alerts
|

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma

Abstract: Dose-escalated treatments, with particular regard to the inclusion or omission of TBI, should be prospectively investigated to find the best high-dose regimen.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
33
1

Year Published

2001
2001
2021
2021

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 42 publications
(35 citation statements)
references
References 8 publications
1
33
1
Order By: Relevance
“…VAD chemotherapy was performed as described previously. 19,21 Written informed consent was obtained from all healthy volunteers and all patients. Our study was approved by the local ethics committee.…”
Section: Patientsmentioning
confidence: 99%
See 4 more Smart Citations
“…VAD chemotherapy was performed as described previously. 19,21 Written informed consent was obtained from all healthy volunteers and all patients. Our study was approved by the local ethics committee.…”
Section: Patientsmentioning
confidence: 99%
“…12,15 A schematic representation of this model is given in Figure 1. An equation based on this pharmacokinetic model describes the mathematical relation between the signal change (S CM (t)/S 0 ; S CM (t): signal at the time point t after start of the contrast medium infusion and S 0 : signal before start of the contrast medium infusion) and the kinetic parameters amplitude A, exchange rate constant k 21 and k 12 (Fig. 1).…”
Section: Computation Of Pharmacokinetic Parameters From Dynamic Mr Immentioning
confidence: 99%
See 3 more Smart Citations